Prospector Partners’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-272,475
Closed -$7.37M 100
2024
Q3
$7.37M Sell
272,475
-402,495
-60% -$10.3M 0.77% 55
2024
Q2
$16.8M Buy
674,970
+293,030
+77% +$8.4M 1.88% 18
2024
Q1
$12.7M Buy
381,940
+25,290
+7% +$864K 1.39% 24
2023
Q4
$12.7M Buy
356,650
+39,275
+12% +$1.25M 1.59% 25
2023
Q3
$10.8M Buy
317,375
+51,050
+19% +$1.94M 1.46% 29
2023
Q2
$10.7M Buy
266,325
+13,850
+5% +$551K 1.49% 28
2023
Q1
$9.92M Buy
+252,475
New +$9.27M 1.38% 31
2022
Q2
Sell
-117,200
Closed -$5.77M 107
2022
Q1
$5.77M Buy
+117,200
New +$6.2M 0.71% 56

Other funds holding XRAY

Prospector Partners's XRAY Position: Q4 2024 in Review

Prospector Partners sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 272,475 shares — an estimated $7.37M sold.

Prospector Partners first reported a position in XRAY in Q1 2022 and held it in 8 quarters. The position peaked at $16.8M in Q2 2024. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Prospector Partners reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Prospector Partners sold 272,475 Dentsply Sirona shares in Q4 2024, an estimated $7.37M.
  • Prospector Partners first reported a position in Dentsply Sirona in Q1 2022 and held it in 8 quarters.
  • Prospector Partners's Dentsply Sirona position peaked at $16.8M in Q2 2024.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Prospector Partners's 13F filing for Q4 2024, filed 13 Feb 2025.